Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2011
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirusVincenzo Cerullo, Iulia Diaconu, Lotta Kangasniemi, et al.
Molecular Therapy Oncolytics|April 24, 2020
Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid TumorsVictor Cervera-Carrascon, Dafne C A Quixabeira, Riikka Havunen, et al.
Molecular Therapy. Oncology|July 1, 2025
Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinomaVictor Arias, Tatiana V Kudling, James H A Clubb, et al.
European Urology|August 4, 2019
Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular ExtensionGreetta Hackman, Kimmo Taari, Teuvo L Tammela, et al.
Cancer Research|February 11, 2012
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patientsSari Pesonen, Iulia Diaconu, Lotta Kangasniemi, et al.
Journal for Immunotherapy of Cancer|January 27, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trialSanteri A Pakola, James H A Clubb, Tatiana V Kudling, et al.
Nature Medicine|April 22, 2003
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunityTyler J Curiel, Shuang Wei, Haidong Dong, et al.
Oncoimmunology|May 6, 2015
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8<sup>+</sup> T-cell response, prominent infiltration of CD8<sup>+</sup> lymphocytes and Th1 type polarizationTuuli Ranki, Timo Joensuu, Elke Jäger, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2025
Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer modelsSanteri A Pakola, Nea Ojala, Tatiana V Kudling, et al.
Cancer Gene Therapy|April 10, 2025
Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomesTatiana V Kudling, Dmitrii Bychkov, James H A Clubb, et al.
Pageof 28